Advanced search

Founder of Oxford University Centre for Business Taxation, Jonathan Richard Symonds is a British businessperson who has been the head of 8 different companies and is Non-Executive Chairman at GlaxoSmithKline Plc and Chairman at Proteus Digital Health, Inc. Mr. Symonds is also on the board of Genomics England Ltd. (former Chairman), Rubius Therapeutics, Inc. and Harrow School and Head-Corporate Finance & Strategy at Mesoblast Ltd. He previously was Chairman at The 100 Group, Chairman-Supervisory Board at Innocoll Holdings Plc Chairman at Innocoll, Inc. and Chairman-Supervisory Board for Innocoll AG (both are subsidiaries of Innocoll Holdings Plc), Chief Financial Officer of AstraZeneca Plc and Director-Finance at Zeneca Group Plc (a subsidiary of AstraZeneca Plc), Chief Financial Officer at Novartis AG, Managing Director at The Goldman Sachs Group, Inc., Director at Accounting Standards Board, Chairman at HSBC Bank Plc and Partner at KPMG LLP (Canada). Jonathan Richard Symonds received an undergraduate degree from the University of Hertfordshire.

Symonds currently works at Berkeley Junior School, as Member-Governors Board.

Patrick Bruce Reith Symonds is currently the Chief Technology Officer at Williamsf1 Team and also holds the position of Chief Technical Officer at Formula One Management Ltd.
He previously worked as an Independent Non-Executive Director at Path Investments Plc.
In 2022, he started working as an Independent Non-Executive Director at DG Innovate Plc, where he worked until 2023.